Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A1 | P04798 | 14/20 | 1.00 |
| ▸ | CYP1B1 | Q16678 | 14/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 13/20 | 1.00 |
| ▸ | PRKDC | P78527 | 4/20 | 1.00 |
| ▸ | CYP19A1 | P11511 | 2/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 2/20 | 1.00 |
| ▸ | ABCC1 | P33527 | 2/20 | 1.00 |
| ▸ | ABCG2 | Q9UNQ0 | 2/20 | 1.00 |
| ▸ | PDE5A | O76074 | 1/20 | 1.00 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 1.00 |
| ▸ | TP53 | P04637 | 1/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 1/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 1/20 | 1.00 |
| ▸ | MAPT | P10636 | 1/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | HPGD | P15428 | 1/20 | 1.00 |
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | CYP2B6 | P20813 | 1/20 | 1.00 |
| ▸ | TACR2 | P21452 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alpha-Naphthoflavone SCHEMBL29351090 | 1.00 | CYP1A1 (1.00) | CYP1A1CYP1B1CYP1A2PRKDCCYP19A1 | |
| Alpha-Naphthoflavone SCHEMBL17292887 | 0.92 | CYP1A1 (0.84) | CYP1A1CYP1B1CYP1A2PRKDCCYP19A1 | |
| Alpha-Naphthoflavone SCHEMBL3665037 | 0.90 | CYP1A1 (0.82) | CYP1A1CYP1B1CYP1A2PRKDCCYP19A1 | |
| Alpha-Naphthoflavone SCHEMBL1906540 | 0.89 | CYP1A1 (0.80) | CYP1A1CYP1B1CYP1A2PRKDCCYP19A1 | |
| SCHEMBL4069839 | 0.88 | CYP1A1 (1.00) | CYP1A1CYP1B1CYP1A2PRKDCCYP19A1 | |
| SCHEMBL20594586 | 0.88 | CYP1A1 (0.78) | CYP1A1CYP1B1CYP1A2PRKDCCYP19A1 | |
| SCHEMBL29407618 | 0.88 | CYP1A1 (0.78) | CYP1A1CYP1B1CYP1A2PRKDCCYP19A1 | |
| SCHEMBL30917246 | 0.88 | CYP1A1 (1.00) | CYP1A1CYP1B1CYP1A2PRKDCCYP19A1 | |
| SCHEMBL31061133 | 0.88 | PRKDC (1.00) | CYP1A1CYP1B1CYP1A2PRKDCCYP19A1 | |
| SCHEMBL31061033 | 0.86 | CYP1A1 (1.00) | CYP1A1CYP1B1CYP1A2PRKDCCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2073 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119138363-A | Method for creating golden pomfret pseudo-male fish | 海南大学三亚南繁研究院 | 2024-12-17 | — | — | CN | claimed |
| CN-118661742-A | Insecticidal composition and application thereof in loquat pest control | 四川农业大学 | 2024-09-20 | — | — | CN | claimed |
| US-20240269066-A1 | USE OF CYP450 INHIBITOR IN INHIBITING OR KILLING MITES AND TREATING XEROPHTHALMIA | PRECVISION BIOTECHNOLOGIES LTD. (CN) | 2024-08-15 | — | — | US | claimed |
| EP-4353264-A1 | USE OF CYP450 INHIBITOR IN INHIBITING OR KILLING MITES AND TREATING DRY EYE SYNDROME | Precvision Biotechnologies Ltd. (CN) | 2024-04-17 | — | — | EP | claimed |
| CN-117897141-A | Flavonoid-rich spray-dried powder | 梅西大学 | 2024-04-16 | — | — | CN | claimed |
| EP-4284386-A1 | FLAVONOID-ENRICHED SPRAY-DRIED POWDER | Massey University (NZ) | 2023-12-06 | — | — | EP | claimed |
| US-20230126434-A1 | OPTIMIZED CRISPR/CAS9 SYSTEMS AND METHODS FOR GENE EDITING IN STEM CELLS | EDITAS MEDICINE, INC. | 2023-04-27 | — | — | US | claimed |
| EP-3524604-B1 | EXPANDED HEMATOPOIETIC STEM CELLS FROM CORD BLOOD AND THEIR THERAPEUTIC USE | NOVARTIS AG (CH) | 2023-03-29 | — | — | EP | claimed |
| US-20230032216-A1 | INTERLEUKIN-4-INDUCED GENE 1 (IL4I1) AND RESPECTIVE METABOLITES AS BIOMARKERS FOR CANCER | Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts Im Neuenheimer Feld 280 (DE) | 2023-02-02 | — | — | US | claimed |
| WO-2022257986-A1 | USE OF CYP450 INHIBITOR IN INHIBITING OR KILLING MITES AND TREATING DRY EYE SYNDROME | 广州岐微生物医药科技有限公司 | 2022-12-15 | — | — | WO | claimed |
| US-6066642-A | FOR SELECTIVELY BLOCKING THE A3 ADENOSINE RECEPTOR OF A MAMMAL | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2000-05-23 | — | — | US | claimed |
| EP-0985166-A1 | METHODS OF IMAGING AND PRINTING WITH A POSITIVE-WORKING INFRARED RADIATION SENSITIVE PRINTING PLATE | Kodak Polychrome Graphics LLC (US) | 2000-03-15 | — | — | EP | claimed |
| EP-0954304-A2 | METHODS FOR REGULATING NICOTINE METABOLISM | Nicogen Inc. (CA) | 1999-11-10 | — | — | EP | claimed |
| US-5886157-A | EXTRACTING THE PROTEIN FROM MEMBRANE CELLS WITH NONIONIC DETERGENT, CENTRIFUGING, PURIFYING THROUGH CHROMATOGRAPHIC COLUMN | VANDERBILT UNIVERSITY (US) | 1999-03-23 | — | — | US | claimed |
| WO-1999007381-A1 | COMPOSITIONS AND TREATMENTS TO REDUCE SIDE EFFECTS OF ADMINISTRATION OF ANDROGENIC TESTOSTERONE PRECURSORS | WEIDER NUTRITION INTERNATIONAL, INC. (US) | 1999-02-18 | — | — | WO | claimed |
| WO-1998054621-A1 | METHODS OF IMAGING AND PRINTING WITH A POSITIVE-WORKING INFRARED RADIATION SENSITIVE PRINTING PLATE | KODAK POLYCHROME GRAPHICS, L.L.C. (US) | 1998-12-03 | — | — | WO | claimed |
| WO-1998003171-A2 | USE OF INHIBITORS OF CYP2A6 FOR REGULATING NICOTINE METABOLISM | NICOGEN INC. (CA) | 1998-01-29 | — | — | WO | claimed |
| US-5663029-A | DEVELOPMENT OF LATENT IMAGE, TRANSFERRING TO FORM RECORDING SHEETS, COATING A SUBSTRATE USING POLYMERS | XEROX CORPORATION (US) | 1997-09-02 | — | — | US | claimed |
| WO-1994023715-A1 | USE OF FLAVONOIDS TO TREAT MULTIDRUG RESISTANT CANCER CELLS | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1994-10-27 | — | — | WO | claimed |
| US-5336685-A | Use of flavonoids to treat multidrug resistant cancer cells | SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH (US) | 1994-08-09 | — | — | US | claimed |